[go: up one dir, main page]

BE1001235A4 - Nouveaux derives azoliques, leur preparation et leur utilisation comme medicaments. - Google Patents

Nouveaux derives azoliques, leur preparation et leur utilisation comme medicaments. Download PDF

Info

Publication number
BE1001235A4
BE1001235A4 BE8701375A BE8701375A BE1001235A4 BE 1001235 A4 BE1001235 A4 BE 1001235A4 BE 8701375 A BE8701375 A BE 8701375A BE 8701375 A BE8701375 A BE 8701375A BE 1001235 A4 BE1001235 A4 BE 1001235A4
Authority
BE
Belgium
Prior art keywords
sep
formula
phenyl
residue
azole derivatives
Prior art date
Application number
BE8701375A
Other languages
English (en)
French (fr)
Original Assignee
Sandoz Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Sa filed Critical Sandoz Sa
Application granted granted Critical
Publication of BE1001235A4 publication Critical patent/BE1001235A4/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
BE8701375A 1986-12-03 1987-12-02 Nouveaux derives azoliques, leur preparation et leur utilisation comme medicaments. BE1001235A4 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3641320 1986-12-03

Publications (1)

Publication Number Publication Date
BE1001235A4 true BE1001235A4 (fr) 1989-08-29

Family

ID=6315380

Family Applications (1)

Application Number Title Priority Date Filing Date
BE8701375A BE1001235A4 (fr) 1986-12-03 1987-12-02 Nouveaux derives azoliques, leur preparation et leur utilisation comme medicaments.

Country Status (24)

Country Link
JP (1) JPH0678318B2 (de)
KR (1) KR880007481A (de)
AT (1) AT395587B (de)
AU (1) AU605522B2 (de)
BE (1) BE1001235A4 (de)
CH (1) CH677925A5 (de)
DK (1) DK631287A (de)
ES (1) ES2010235A6 (de)
FI (1) FI875300L (de)
FR (1) FR2607810B1 (de)
GB (1) GB2199579B (de)
GR (1) GR871897B (de)
HU (1) HU198694B (de)
IL (1) IL84665A (de)
IT (1) IT1211944B (de)
LU (1) LU87063A1 (de)
MY (1) MY103004A (de)
NL (1) NL8702897A (de)
NZ (1) NZ222765A (de)
PH (1) PH24666A (de)
PL (1) PL151588B1 (de)
PT (1) PT86255B (de)
SE (1) SE8704792L (de)
ZA (1) ZA879093B (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8814277D0 (en) * 1988-06-16 1988-07-20 Glaxo Group Ltd Chemical compounds
ATE186052T1 (de) * 1991-09-02 1999-11-15 Yamanouchi Pharma Co Ltd Triazolylierte tertiäre aminverbindungen oder ihre salze
GB9409882D0 (en) * 1994-05-18 1994-07-06 Sandoz Ltd Organic compounds
GB0128415D0 (en) * 2001-11-27 2002-01-16 Univ Sheffield Medicaments

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0239246A1 (de) * 1986-02-24 1987-09-30 Shikoku Chemicals Corporation Imidazolverbindungen, Verfahren zu deren Herstellung und Methode zur Vulkanisation von Epoxy-Harzen

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT382868B (de) * 1983-03-11 1987-04-27 Sandoz Ag Verfahren zur herstellung neuer azolderivate und deren salze

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0239246A1 (de) * 1986-02-24 1987-09-30 Shikoku Chemicals Corporation Imidazolverbindungen, Verfahren zu deren Herstellung und Methode zur Vulkanisation von Epoxy-Harzen

Also Published As

Publication number Publication date
IL84665A (en) 1991-11-21
LU87063A1 (fr) 1988-07-14
AT395587B (de) 1993-01-25
JPH0678318B2 (ja) 1994-10-05
FI875300A0 (fi) 1987-12-01
AU8196287A (en) 1988-06-16
PH24666A (en) 1990-09-07
FI875300L (fi) 1988-06-04
GB2199579A (en) 1988-07-13
MY103004A (en) 1993-03-31
DK631287A (da) 1988-06-04
IT1211944B (it) 1989-11-08
IT8748656A0 (it) 1987-12-01
CH677925A5 (de) 1991-07-15
PT86255A (en) 1988-06-01
SE8704792L (sv) 1988-06-04
NZ222765A (en) 1990-11-27
PL151588B1 (en) 1990-09-28
NL8702897A (nl) 1988-07-01
KR880007481A (ko) 1988-08-27
HU198694B (en) 1989-11-28
AU605522B2 (en) 1991-01-17
IL84665A0 (en) 1988-05-31
GB2199579B (en) 1990-07-18
JPS63145270A (ja) 1988-06-17
PL269180A1 (en) 1988-08-18
PT86255B (pt) 1990-11-07
ATA316887A (de) 1992-06-15
ZA879093B (en) 1989-07-26
DK631287D0 (da) 1987-12-01
SE8704792D0 (sv) 1987-12-01
HUT45506A (en) 1988-07-28
ES2010235A6 (es) 1989-11-01
FR2607810A1 (fr) 1988-06-10
GR871897B (en) 1988-04-04
GB8727978D0 (en) 1988-01-06
FR2607810B1 (fr) 1989-12-01

Similar Documents

Publication Publication Date Title
EP0099802B1 (de) Thieno(3,2-c)pyridinderivate, Verfahren zu ihrer Herstellung und ihre therapeutische Anwendung
BE851310A (fr) Nouveaux derives de la tetrahydro-equinocandine b
CA1190226A (fr) Procede de preparation de nouvelles pyrimido quinoxalines et de leurs sels
EP0624575A1 (de) Substituierte Indole und diese enthaltende Arzneimittel
EP0117771B1 (de) Imino-2-pyrrolidine, Verfahren zu ihrer Herstellung und ihre therapeutische Verwendung
BE1001235A4 (fr) Nouveaux derives azoliques, leur preparation et leur utilisation comme medicaments.
EP2419422B1 (de) Imidazolidin-2,4-dionderivate und deren verwendung als medikament
EP0004494B1 (de) 1,3-Dihydro-3-(1-(2-(2,3-dihydro-1,4-benzodioxin-2-yl)2-hydroxy-äthyl)piperidin-4-yl)2H-indol-2-on Derivate, Verfahren zu ihrer Herstellung, ihre Verwendung als Arzneimittel und diese enthaltende pharmazeutische Zubereitungen
EP0021924B1 (de) Indol-Derivate, Verfahren zu ihrer Herstellung, ihre Verwendung als Arzneimittel und sie enthaltende pharmazeutische Zusammensetzungen
EP0002401B1 (de) Naphtalen-Derivate, Verfahren zu deren Herstellung und deren Verwendung in der Therapeutik
EP1793834B1 (de) Indolin-2-one-pyridin-derivate, herstellung und therapeutische verwendung dafür
EP0076713B1 (de) Aminomethyl 1H-Indole 4-Methanol Derivate und ihre Salze, Verfahren und Zwischenprodukte zu ihren Herstellung, Verwendung als Heilmittel und Zusammenstellungen die sie enthalten
EP0168309B1 (de) Isoxazolochinolinonderivate, Verfahren und Zwischenprodukte zu ihrer Herstellung, Verwendung als Arzneimittel und die sie enthaltenden Zubereitungen
WO1992021664A1 (fr) Nouveaux derives de l'oxazole, leur preparation et les compositions qui les contiennent
EP0733627B1 (de) Thiophenverbindungen, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Zubereitungen
FR2659233A1 (fr) Nouvelle utilisation de composes anti-progestomimetiques chez les animaux d'elevage.
WO1992021665A1 (fr) Nouveaux derives de l'oxazole et leur preparation
EP1674101B1 (de) Benzo[b]pyrano[3,2-h]acridin-7-one-zimtsäurederivate, Verfahren zu deren Herstellung und pharmazeutische Zusammensetzungen diese enthaltend
CA1230128A (fr) Procede pour la preparation de derives acetyleniques possedant une activite d'inhibiteurs d'enzyme et les derives ainsi obtenus
EP0032889B1 (de) 1,10-Dimethyl-oxayohimban-Derivate und sie enthaltende Arzneimittel
FR2600254A1 (fr) Derives methylenes des androstene-4 diones-3, 17, leur procede de preparation, et leur application comme medicaments
CH669599A5 (de)
FR2789393A1 (fr) Lactol steroidique
BE879248A (fr) Nouvelles amines cycliques substituees, leur preparation et leur application comme medicaments
FR2617165A1 (fr) Derives du dimethyl-2, 2 chromannol-3

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: S.A. SANDOZ

Effective date: 19931231